首页 > 最新文献

Medical Research Archives最新文献

英文 中文
Laparoscopic Common Bile Duct Exploration for Stones at a Resource Poor Hospital in Trinidad & Tobago: A Retrospective Study 特立尼达一家资源贫乏医院的腹腔镜胆总管探查术多巴哥:回顾性研究
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i8.4179
Shamir Cawich, Fawwaz Mohammed, Vijay Narayansingh
exploration at the time of cholecystectomy because exploration is perceived to have low clearance rates. We routinely perform laparoscopic explorations for CBD stones at the Port of Spain General Hospital in Trinidad & Tobago. This retrospective study sought to document outcomes after laparoscopic CBD exploration. Methods: We identified all patients who underwent laparoscopic CBD exploration for stone extraction at the General Hospital in Port of Spain over a ten-year period from January 1, 2013 to January 30, 2023. The following data were extracted: demographic details, operating time, stone clearance rates, retained stone rates, conversions, complications. All data were entered into an excel database and the data were analyzed with SPSS version 20. Results: Intra-operative cholangiograms were performed in 49 patients, and CBD stones identified in 12 (25%) patients at a mean age of 48.7+/- 8.63 years. These patients underwent laparoscopic CBD exploration without prior endoscopic retrograde cholangio-pancreatography. The mean stone burden was 4.7+/-2.54 stones. Four (33%) patients had attempts at trans-cystic exploration, and they all required choledochotomies to complete CBD exploration. Eight patients had initial attempts at choledochotomy for stone extraction. The mean operating time for laparoscopic cholecystectomy, operative cholangiography and CBD exploration with duct clearance was 169.6+/-35.1 minutes. There were 2 (17%) conversions, 1 (8.3%) complication (bile leak) and no mortality. Stone clearance rate was 91.7% (11). The mean duration of hospitalization was 0.6 days. There were no instances of retained or recurrent CBD stones in this series. Conclusions: While laparoscopic CBD exploration does demand increased skill sets, such as laparoscopic suturing, mastering duct exploration techniques, interpreting biliary anatomy and operative cholangiography, we have shown that it is feasible in the resource poor Caribbean setting. Surgeons planning to perform laparoscopic CBD exploration should have a working knowledge of biliary anatomy and variations and the ability to suture laparoscopically.
胆囊切除术时探查,因为探查被认为清除率低。在特立尼达的西班牙港总医院,我们定期对CBD结石进行腹腔镜检查。多巴哥。本回顾性研究旨在记录腹腔镜下CBD探查后的结果。方法:我们确定了2013年1月1日至2023年1月30日十年间在西班牙港总医院接受腹腔镜CBD探查以取出结石的所有患者。提取以下数据:人口统计资料、手术时间、结石清除率、结石残留率、转化率、并发症。所有数据输入excel数据库,并使用SPSS version 20对数据进行分析。结果:49例患者行术中胆管造影,12例(25%)患者发现CBD结石,平均年龄48.7±8.63岁。这些患者在没有内镜逆行胆道-胰腺造影的情况下接受了腹腔镜下的CBD探查。平均结石负担为4.7+/-2.54结石。4例(33%)患者尝试跨囊探查,他们都需要胆道切开术来完成CBD探查。8例患者最初尝试胆总管切开术取出结石。腹腔镜胆囊切除术、手术胆道造影和CBD探查经胆管清除的平均手术时间为169.6+/-35.1分钟。2例(17%)转化,1例(8.3%)并发症(胆漏),无死亡。结石清除率91.7%(11)。平均住院时间为0.6 d。在这个系列中没有保留或复发的CBD结石的实例。结论:虽然腹腔镜下CBD探查确实需要提高技能,如腹腔镜缝合、掌握导管探查技术、解释胆道解剖和手术胆道造影,但我们已经表明,在资源贫乏的加勒比地区,这是可行的。计划进行腹腔镜CBD探查的外科医生应具备胆道解剖和变异的工作知识以及腹腔镜缝合的能力。
{"title":"Laparoscopic Common Bile Duct Exploration for Stones at a Resource Poor Hospital in Trinidad & Tobago: A Retrospective Study","authors":"Shamir Cawich, Fawwaz Mohammed, Vijay Narayansingh","doi":"10.18103/mra.v11i8.4179","DOIUrl":"https://doi.org/10.18103/mra.v11i8.4179","url":null,"abstract":"exploration at the time of cholecystectomy because exploration is perceived to have low clearance rates. We routinely perform laparoscopic explorations for CBD stones at the Port of Spain General Hospital in Trinidad & Tobago. This retrospective study sought to document outcomes after laparoscopic CBD exploration. Methods: We identified all patients who underwent laparoscopic CBD exploration for stone extraction at the General Hospital in Port of Spain over a ten-year period from January 1, 2013 to January 30, 2023. The following data were extracted: demographic details, operating time, stone clearance rates, retained stone rates, conversions, complications. All data were entered into an excel database and the data were analyzed with SPSS version 20. Results: Intra-operative cholangiograms were performed in 49 patients, and CBD stones identified in 12 (25%) patients at a mean age of 48.7+/- 8.63 years. These patients underwent laparoscopic CBD exploration without prior endoscopic retrograde cholangio-pancreatography. The mean stone burden was 4.7+/-2.54 stones. Four (33%) patients had attempts at trans-cystic exploration, and they all required choledochotomies to complete CBD exploration. Eight patients had initial attempts at choledochotomy for stone extraction. The mean operating time for laparoscopic cholecystectomy, operative cholangiography and CBD exploration with duct clearance was 169.6+/-35.1 minutes. There were 2 (17%) conversions, 1 (8.3%) complication (bile leak) and no mortality. Stone clearance rate was 91.7% (11). The mean duration of hospitalization was 0.6 days. There were no instances of retained or recurrent CBD stones in this series. Conclusions: While laparoscopic CBD exploration does demand increased skill sets, such as laparoscopic suturing, mastering duct exploration techniques, interpreting biliary anatomy and operative cholangiography, we have shown that it is feasible in the resource poor Caribbean setting. Surgeons planning to perform laparoscopic CBD exploration should have a working knowledge of biliary anatomy and variations and the ability to suture laparoscopically.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135151734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing challenges and opportunities of treating breast cancer in Lesotho 评估莱索托治疗乳腺癌的挑战和机遇
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4583
Maseabata Ramathebane, Lineo Maja, Mopa Sooro, Molungoa Sello, Motselisi Mokhethi, Kabelo Mputsoe
Background: It has been estimated that, more than 60% of the new breast cancer cases and 70% of related deaths will be seen in Low-Middle Income Countries in the coming 20 years. In Lesotho, out of 228 women, 177 had heard about breast cancer while 72.9% had heard of breast cancer screening. Given limited treatment facilities and options in Lesotho, many patients die soon after diagnosis, before they are able to access treatment; to date this cannot be quantified. Another challenge that affects breast cancer management is treatment and travel-related costs, particularly for those not living close to the medical centre. Most patients are coming with advanced disease stage and are sent home for home-based care, some of which could have been prevented with early screening. Aim: The aim of study is to determine challenges faced by breast cancer patients, the cost to the health system and the opportunities this may bring to the country. Methods: A quantitative cross-sectional, prospective and retrospective study was conducted on 45 breast cancer patients who were initiated chemotherapy at the only cancer treatment centre in Lesotho; Senkatana oncology clinic located at the Botshabelo complex in Maseru. Results: The majority of patients were facing challenges of arranging transport to the doctor (83.3%, n=15), of being far from the healthcare facilities even if transportation was available (77.8%, n=14), paying for healthcare (83.3%, n=15), paying for transport (77.8%, n=14) and paying for diagnostic test (88.9%, n=16) in all ages. Majority of patients who presented for care and treatment late faced challenges more than those who presented earlier. Diagnostic and monitoring laboratory test constituted 64.5% of total direct medical costs followed by 24.7 % from chemotherapy. Conclusion: The challenges faced by breast cancer patients are of financial and practical nature and they get higher for patients who presented at advanced stage for care and treatment. In order to improve breast cancer care and treatment outcome at lower costs efforts for breast cancer awareness need to be intensified so that patients presented early at the health centers. In term of direct medical cost, the largest cost came from the diagnostic and monitoring laboratory tests.
背景:据估计,在未来20年内,60%以上的乳腺癌新病例和70%以上的相关死亡将发生在中低收入国家。在莱索托,228名妇女中,177人听说过乳腺癌,72.9%的人听说过乳腺癌筛查。由于莱索托的治疗设施和选择有限,许多患者在诊断后不久就在能够获得治疗之前死亡;到目前为止,这种情况还无法量化。影响乳腺癌管理的另一个挑战是治疗和与旅行有关的费用,特别是对于那些住在医疗中心附近的人。大多数患者都是疾病晚期,被送回家接受家庭护理,其中一些本来可以通过早期筛查来预防。目的:研究的目的是确定乳腺癌患者面临的挑战,卫生系统的成本以及这可能给国家带来的机会。方法:对在莱索托唯一的癌症治疗中心开始化疗的45例乳腺癌患者进行定量横断面、前瞻性和回顾性研究;位于马塞卢Botshabelo综合医院的Senkatana肿瘤诊所。结果:所有年龄段的患者中,大多数患者面临的挑战是安排接送(83.3%,n=15)、即使有交通工具也远离医疗机构(77.8%,n=14)、支付医疗费用(83.3%,n=15)、支付交通费用(77.8%,n=14)和支付诊断检查费用(88.9%,n=16)。大多数就诊较晚的患者比就诊较早的患者面临更多的挑战。诊断和监测实验室检查占直接医疗费用总额的64.5%,其次是化疗费用24.7%。结论:乳腺癌患者所面临的挑战具有经济和现实的双重性质,晚期患者在护理和治疗方面面临的挑战更高。为了以较低的成本改善乳腺癌的护理和治疗结果,需要加强对乳腺癌的认识,以便患者尽早到保健中心就诊。在直接医疗费用方面,最大的费用来自诊断和监测实验室检查。
{"title":"Assessing challenges and opportunities of treating breast cancer in Lesotho","authors":"Maseabata Ramathebane, Lineo Maja, Mopa Sooro, Molungoa Sello, Motselisi Mokhethi, Kabelo Mputsoe","doi":"10.18103/mra.v11i10.4583","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4583","url":null,"abstract":"Background: It has been estimated that, more than 60% of the new breast cancer cases and 70% of related deaths will be seen in Low-Middle Income Countries in the coming 20 years. In Lesotho, out of 228 women, 177 had heard about breast cancer while 72.9% had heard of breast cancer screening. Given limited treatment facilities and options in Lesotho, many patients die soon after diagnosis, before they are able to access treatment; to date this cannot be quantified. Another challenge that affects breast cancer management is treatment and travel-related costs, particularly for those not living close to the medical centre. Most patients are coming with advanced disease stage and are sent home for home-based care, some of which could have been prevented with early screening. Aim: The aim of study is to determine challenges faced by breast cancer patients, the cost to the health system and the opportunities this may bring to the country. Methods: A quantitative cross-sectional, prospective and retrospective study was conducted on 45 breast cancer patients who were initiated chemotherapy at the only cancer treatment centre in Lesotho; Senkatana oncology clinic located at the Botshabelo complex in Maseru. Results: The majority of patients were facing challenges of arranging transport to the doctor (83.3%, n=15), of being far from the healthcare facilities even if transportation was available (77.8%, n=14), paying for healthcare (83.3%, n=15), paying for transport (77.8%, n=14) and paying for diagnostic test (88.9%, n=16) in all ages. Majority of patients who presented for care and treatment late faced challenges more than those who presented earlier. Diagnostic and monitoring laboratory test constituted 64.5% of total direct medical costs followed by 24.7 % from chemotherapy. Conclusion: The challenges faced by breast cancer patients are of financial and practical nature and they get higher for patients who presented at advanced stage for care and treatment. In order to improve breast cancer care and treatment outcome at lower costs efforts for breast cancer awareness need to be intensified so that patients presented early at the health centers. In term of direct medical cost, the largest cost came from the diagnostic and monitoring laboratory tests.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134889857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE USE OF SURGICAL SUTURE AS AN IMPLANT PLACEMENT GUIDE – A RETROSPECTIVE OVER VIEW OF OVER TWO DECADES OF IMPLANT THERAPY 外科缝线作为种植体放置指南的使用-回顾超过二十年的种植体治疗
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4428
M. Lanka, M. Glenn, S. Sagrika, P. Tanvi, D. Zara
In the era of digital dentistry, positioning of implants can by designed with the help of CBCT and CAD CAM. Surgical guide can be made to direct the implant placement in bone. Although various researchers showed the importance of 3D planning but because of chances of errors at various levels of digital protocols may lead to deviations. Even no data is available to confirm the accuracy of GBR with digital workflow. This retrospective analysis of simple suture placement technique in anterior edentulous region will make clinicians to understand the positioning of drills, anatomical variations, directions and placements of implants, need of bone grafting and implant emergence.
在数字牙科时代,种植体的定位可以借助CBCT和CAD CAM进行设计。可以制作手术指南来指导种植体在骨内的放置。虽然各种研究人员都表明了3D规划的重要性,但由于数字协议在不同层次上的错误可能导致偏差。即使没有数据可以证实数字化工作流程下GBR的准确性。通过对前无牙区简单缝线置入技术的回顾性分析,使临床医生了解钻头的定位、解剖变化、种植体的方向和放置、植骨的需要和种植体的出现。
{"title":"THE USE OF SURGICAL SUTURE AS AN IMPLANT PLACEMENT GUIDE – A RETROSPECTIVE OVER VIEW OF OVER TWO DECADES OF IMPLANT THERAPY","authors":"M. Lanka, M. Glenn, S. Sagrika, P. Tanvi, D. Zara","doi":"10.18103/mra.v11i10.4428","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4428","url":null,"abstract":"In the era of digital dentistry, positioning of implants can by designed with the help of CBCT and CAD CAM. Surgical guide can be made to direct the implant placement in bone. Although various researchers showed the importance of 3D planning but because of chances of errors at various levels of digital protocols may lead to deviations. Even no data is available to confirm the accuracy of GBR with digital workflow. This retrospective analysis of simple suture placement technique in anterior edentulous region will make clinicians to understand the positioning of drills, anatomical variations, directions and placements of implants, need of bone grafting and implant emergence.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"71 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134890113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Much Do We Know About the Mouse Respiratory Epithelial Stem Cells? 我们对小鼠呼吸道上皮干细胞了解多少?
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4522
Christian Elmshaeuser, Ina Zoeller, Darisuren Anhlan, Ewald Beck, Bruno Peault, Olivier Tabary, Una Chen
Background-Purpose of this study: Tissue-specific stem cell lines are useful tools for cell biology studies. Information on respiratory tissue cell lines is limited. A doxycycline-regulated epithelial precursor cell line was established from the lung tissue of a tTAxSV40 Tag double transgenic mouse. In this study, we have characterized this cell line in vitro & in vivo, and found to mimic a rare subpopulation of club- and pneumocyte type II-dual cells. Methods: It was partially characterized using cell viability and death assays, H3-thymidine incorporation assay, chloride efflux assay, Western blotting of proteins secreted, RT-PCR assays for RNA isolated. In addition, immune-deficient SCID mice were used as hosts for implantation of this precursor cell line, and feed with/without doxycycline containing water. Immunofluorescent typing using different antibodies were used to characterize the implanted lung. Results: This cell line was found to mimic a rare subpopulation of club- and pneumocyte type II- dual cells with multiple phenotypes. Cell growth was doxycycline-regulated and observed only when doxycycline was omitted from the medium or present at concentrations up to 1 µg/ml, higher concentrations were inhibitory. ACT+ ciliated cells were found upon implantation into immune-deficient mice, in addition. Cell growth was doxycycline-regulated in vitro. When transplanted subcutaneously into immune-deficient mice, these cells migrated to the lung to form organized chimeric structures of donor and host origins, with club cells in the terminal bronchioles, ACT+ ciliated cells along the epithelial lining, and pneumocyte type II-cells in the alveolar interstices. No such homing of donor cells to the lung was observed when the implanted mice were fed doxycycline-containing water. Discussions-Conclusions: This lung stem cell line might be able to provide us with an insight into the differentiation pathway of lung epithelial cells as well as with some understanding of the nature of air trophic-pulmonary epithelial cells. The results of this study underline the possibility of a future application for somatic (stem / precursor) cells in tissue replacement and tissue engineering of the damaged lung. Its ability to secrete and deliver soluble protein, might be a potential novel way for drug delivery. In addition, stem cells are thought to proliferate and differentiate in response to a deficiency or as a result of injury. Successful migration to the target organ and subsequent maturation of these precursors could be attributed to a requirement of lung stem cells to search for an aerated environment. Our findings challenge some current concepts of stem cell biology.This lung stem cell line may become a rich source of cells for tissue engineering and cell-based therapy for lung injury. The route and protocol established for cell introduction into the lung may provide a novel alternative to delivery of soluble protein substances through the airways. This lung
研究背景:组织特异性干细胞系是细胞生物学研究的重要工具。关于呼吸组织细胞系的信息有限。从tTAxSV40标签双转基因小鼠肺组织中建立了多西环素调控的上皮前体细胞系。在这项研究中,我们在体外对该细胞系进行了表征。体内,并发现模仿俱乐部和肺细胞ii型双细胞的罕见亚群。方法:采用细胞活力和死亡试验、h3 -胸腺嘧啶掺入试验、氯离子外排试验、分泌蛋白Western blotting、分离RNA RT-PCR等方法对其进行部分鉴定。此外,以免疫缺陷SCID小鼠为宿主,植入该前细胞系,并给予/不给予强力霉素含水喂养。使用不同抗体的免疫荧光分型来描述植入肺的特征。结果:该细胞系被发现模拟了俱乐部和肺细胞II型双细胞的罕见亚群,具有多种表型。多西环素调节细胞生长,只有当多西环素从培养基中省略或浓度高达1 μ g/ml时,细胞生长才会受到抑制。此外,在免疫缺陷小鼠体内植入ACT+纤毛细胞。多西环素在体外调节细胞生长。当将这些细胞皮下移植到免疫缺陷小鼠体内时,这些细胞迁移到肺部,形成供体和宿主来源的有组织嵌合结构,其中俱乐部细胞位于末端细支气管,ACT+纤毛细胞沿上皮内壁,ii型肺细胞位于肺泡间隙。当给植入的小鼠喂食含强力霉素的水时,没有观察到供体细胞归巢到肺部。结论:该肺干细胞系可能为我们了解肺上皮细胞的分化途径以及对空气营养型肺上皮细胞的性质有一定的了解。本研究的结果强调了体细胞(干/前体细胞)在肺损伤组织替代和组织工程中的应用前景。它具有分泌和传递可溶性蛋白的能力,可能是一种潜在的药物传递新途径。此外,干细胞被认为是由于缺乏或损伤而增殖和分化的。成功迁移到靶器官和这些前体随后的成熟可能归因于肺干细胞寻找通气环境的要求。我们的发现挑战了当前干细胞生物学的一些概念。该肺干细胞系可能成为组织工程和肺损伤细胞治疗的丰富细胞来源。建立细胞导入肺的途径和方案可能为通过气道输送可溶性蛋白物质提供一种新的替代方案。这种肺干细胞系也可能被修改,为筛选抗呼吸道感染的药物提供模型。
{"title":"How Much Do We Know About the Mouse Respiratory Epithelial Stem Cells?","authors":"Christian Elmshaeuser, Ina Zoeller, Darisuren Anhlan, Ewald Beck, Bruno Peault, Olivier Tabary, Una Chen","doi":"10.18103/mra.v11i10.4522","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4522","url":null,"abstract":"Background-Purpose of this study: Tissue-specific stem cell lines are useful tools for cell biology studies. Information on respiratory tissue cell lines is limited. A doxycycline-regulated epithelial precursor cell line was established from the lung tissue of a tTAxSV40 Tag double transgenic mouse. In this study, we have characterized this cell line in vitro & in vivo, and found to mimic a rare subpopulation of club- and pneumocyte type II-dual cells. Methods: It was partially characterized using cell viability and death assays, H3-thymidine incorporation assay, chloride efflux assay, Western blotting of proteins secreted, RT-PCR assays for RNA isolated. In addition, immune-deficient SCID mice were used as hosts for implantation of this precursor cell line, and feed with/without doxycycline containing water. Immunofluorescent typing using different antibodies were used to characterize the implanted lung. Results: This cell line was found to mimic a rare subpopulation of club- and pneumocyte type II- dual cells with multiple phenotypes. Cell growth was doxycycline-regulated and observed only when doxycycline was omitted from the medium or present at concentrations up to 1 µg/ml, higher concentrations were inhibitory. ACT+ ciliated cells were found upon implantation into immune-deficient mice, in addition. Cell growth was doxycycline-regulated in vitro. When transplanted subcutaneously into immune-deficient mice, these cells migrated to the lung to form organized chimeric structures of donor and host origins, with club cells in the terminal bronchioles, ACT+ ciliated cells along the epithelial lining, and pneumocyte type II-cells in the alveolar interstices. No such homing of donor cells to the lung was observed when the implanted mice were fed doxycycline-containing water. Discussions-Conclusions: This lung stem cell line might be able to provide us with an insight into the differentiation pathway of lung epithelial cells as well as with some understanding of the nature of air trophic-pulmonary epithelial cells. The results of this study underline the possibility of a future application for somatic (stem / precursor) cells in tissue replacement and tissue engineering of the damaged lung. Its ability to secrete and deliver soluble protein, might be a potential novel way for drug delivery. In addition, stem cells are thought to proliferate and differentiate in response to a deficiency or as a result of injury. Successful migration to the target organ and subsequent maturation of these precursors could be attributed to a requirement of lung stem cells to search for an aerated environment. Our findings challenge some current concepts of stem cell biology.This lung stem cell line may become a rich source of cells for tissue engineering and cell-based therapy for lung injury. The route and protocol established for cell introduction into the lung may provide a novel alternative to delivery of soluble protein substances through the airways. This lung","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134891146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Insight into Emergent Ways of Stemming the Tide of Glaucoma Scourge 对遏制青光眼祸害浪潮的紧急方法的洞察
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4519
Timothy Oladosu, Aderonke Awoseemo
Glaucoma, the silent thief of sight remains a beglaring eye condition leading to optic nerve damage due to elevated pressure within the eye. It is one of the major irreversible blinding eye conditions in the world, perhaps devastating as it is mostly without symptoms till considerable vision is lost. This comprehensive article acclaim the silentious nature of this ailment; highlights the distinctive features of glaucoma among other eye disorders; provides practical measures to optimize one’s eye health; shares experiences and feedbacks from people with glaucoma; and identifies promising prospects of glaucoma diagnosis and management. The information therein aims to create awareness about the course and scourge of glaucoma to readers, as well as call the attention of the eye health practitioners to the perceived challenges encountered by patients with glaucoma with the aim of improving consumer’s outcome and quality of life.
青光眼,无声的视觉窃贼,是一种由于眼压升高导致视神经损伤的严重眼病。它是世界上主要的不可逆致盲眼病之一,可能具有破坏性,因为它通常没有症状,直到相当大的视力丧失。这篇全面的文章赞扬了这种疾病沉默的本质;强调青光眼在其他眼病中的独特特征;提供切实可行的措施,使眼睛更健康;分享青光眼患者的经验和反馈;并指出了青光眼的诊断和治疗前景。其中的信息旨在提高读者对青光眼的病程和危害的认识,并呼吁眼科医生注意青光眼患者所面临的挑战,以改善消费者的治疗结果和生活质量。
{"title":"An Insight into Emergent Ways of Stemming the Tide of Glaucoma Scourge","authors":"Timothy Oladosu, Aderonke Awoseemo","doi":"10.18103/mra.v11i10.4519","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4519","url":null,"abstract":"Glaucoma, the silent thief of sight remains a beglaring eye condition leading to optic nerve damage due to elevated pressure within the eye. It is one of the major irreversible blinding eye conditions in the world, perhaps devastating as it is mostly without symptoms till considerable vision is lost. This comprehensive article acclaim the silentious nature of this ailment; highlights the distinctive features of glaucoma among other eye disorders; provides practical measures to optimize one’s eye health; shares experiences and feedbacks from people with glaucoma; and identifies promising prospects of glaucoma diagnosis and management. The information therein aims to create awareness about the course and scourge of glaucoma to readers, as well as call the attention of the eye health practitioners to the perceived challenges encountered by patients with glaucoma with the aim of improving consumer’s outcome and quality of life.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134980362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Technique to Temporize a Destructive Common Bile Duct Injury in an Unstable Poly-Trauma Patient 一种新技术在不稳定多发创伤患者中抢救破坏性胆总管损伤
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i9.4264
Emery Edmondson, Sean Ramras, Rebecca Jugo, Mohammad Ali, Meagan Kozhimala, Paul Fata, Colline Wong, Peter Zdankiewicz, Zhongqiu Zhang
We report a case of a 26-year-old patient presenting as a polytrauma with multiple devastating injuries, including a 1 cm destructive injury to the common bile duct (CBD) along with a laceration to the inferior vena cava (IVC). Studies on temporization strategies for common bile duct injuries in the context of damage control surgery are scarce, and guidelines for management of such injuries are limited due to low quality evidence. Surgical treatment for injuries to the extrahepatic bile ducts are individualized based on location, severity, and stability. In stable patients with less than 50% circumference injuries and healthy common bile duct margins, definitive repair can be attempted primarily. Destructive injuries that encompass greater than 50% circumference in stable patients are more challenging and there is controversy surrounding early versus delayed biliary reconstruction. In this case, an adequately sized T-tube was not available, and closed suction drainage was dismissed due to potential complications with early reconstruction. Due to the patient's critical condition and extraordinary circumstances, a LeMaitre carotid shunt was used to temporize the common bile duct injury for 6 days, a technique not previously described. The patient was then reconstructed with a hepaticojejunostomy in Roux-en-y fashion with a favorable outcome. We believe that this method of temporization may be an especially useful tool in the armamentarium of the surgeon practicing in an austere environment.
我们报告一例26岁的患者,表现为多发创伤,伴有多处破坏性损伤,包括1厘米的胆总管(CBD)破坏性损伤以及下腔静脉(IVC)撕裂伤。在损伤控制手术的背景下,关于胆总管损伤的时间策略的研究很少,而且由于证据质量低,此类损伤的治疗指南也有限。肝外胆管损伤的手术治疗应根据部位、严重程度和稳定性进行个体化治疗。对于周围损伤小于50%且胆总管边缘健康的稳定患者,可以首先尝试最终修复。稳定性患者的破坏性损伤周长大于50%更具挑战性,关于早期还是延迟胆道重建存在争议。在本病例中,由于无法获得足够大小的t型管,由于早期重建的潜在并发症,关闭吸引引流被取消。由于患者病情危重和特殊情况,我们使用LeMaitre颈动脉分流术暂时修复胆总管损伤6天,这是一种以前没有描述过的技术。然后,患者以Roux-en-y方式重建肝空肠吻合术,结果良好。我们相信,这种方法的时间可能是一个特别有用的工具,在外科医生的装备,在一个严峻的环境下执业。
{"title":"A Novel Technique to Temporize a Destructive Common Bile Duct Injury in an Unstable Poly-Trauma Patient","authors":"Emery Edmondson, Sean Ramras, Rebecca Jugo, Mohammad Ali, Meagan Kozhimala, Paul Fata, Colline Wong, Peter Zdankiewicz, Zhongqiu Zhang","doi":"10.18103/mra.v11i9.4264","DOIUrl":"https://doi.org/10.18103/mra.v11i9.4264","url":null,"abstract":"We report a case of a 26-year-old patient presenting as a polytrauma with multiple devastating injuries, including a 1 cm destructive injury to the common bile duct (CBD) along with a laceration to the inferior vena cava (IVC). Studies on temporization strategies for common bile duct injuries in the context of damage control surgery are scarce, and guidelines for management of such injuries are limited due to low quality evidence. Surgical treatment for injuries to the extrahepatic bile ducts are individualized based on location, severity, and stability. In stable patients with less than 50% circumference injuries and healthy common bile duct margins, definitive repair can be attempted primarily. Destructive injuries that encompass greater than 50% circumference in stable patients are more challenging and there is controversy surrounding early versus delayed biliary reconstruction. In this case, an adequately sized T-tube was not available, and closed suction drainage was dismissed due to potential complications with early reconstruction. Due to the patient's critical condition and extraordinary circumstances, a LeMaitre carotid shunt was used to temporize the common bile duct injury for 6 days, a technique not previously described. The patient was then reconstructed with a hepaticojejunostomy in Roux-en-y fashion with a favorable outcome. We believe that this method of temporization may be an especially useful tool in the armamentarium of the surgeon practicing in an austere environment.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135311349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The high prevalence of COVID-19 in Diabetics: Unveiling the intricate interplay between viral and diabetic mechanisms COVID-19在糖尿病患者中的高患病率:揭示病毒与糖尿病机制之间复杂的相互作用
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4540
Dennis Mathew
Diabetics have an increased risk of contracting COVID-19 infection and tend to have more severe symptoms. This review explores the potential mechanisms underlying the high prevalence of COVID-19 infections in individuals with diabetes. It reviews the emerging evidence about the interactions between viral and diabetic pathways, particularly how diabetes physiology could contribute to higher viral reception, viral entry and pathogenicity, and the severity of disease symptoms. Finally, it examines the challenges we face in studying these mechanisms and offers new strategies that might assist our fight against current and future pandemics.
糖尿病患者感染COVID-19的风险增加,症状往往更严重。本综述探讨了糖尿病患者中高流行率COVID-19感染的潜在机制。它回顾了关于病毒和糖尿病途径之间相互作用的新证据,特别是糖尿病生理学如何促进更高的病毒接受、病毒进入和致病性,以及疾病症状的严重程度。最后,它审查了我们在研究这些机制时面临的挑战,并提出了可能有助于我们防治当前和未来流行病的新战略。
{"title":"The high prevalence of COVID-19 in Diabetics: Unveiling the intricate interplay between viral and diabetic mechanisms","authors":"Dennis Mathew","doi":"10.18103/mra.v11i10.4540","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4540","url":null,"abstract":"Diabetics have an increased risk of contracting COVID-19 infection and tend to have more severe symptoms. This review explores the potential mechanisms underlying the high prevalence of COVID-19 infections in individuals with diabetes. It reviews the emerging evidence about the interactions between viral and diabetic pathways, particularly how diabetes physiology could contribute to higher viral reception, viral entry and pathogenicity, and the severity of disease symptoms. Finally, it examines the challenges we face in studying these mechanisms and offers new strategies that might assist our fight against current and future pandemics.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135360563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complication Rate After Carotid Endarterectomy Comparing Patch Angioplasty and Primary Closure: Long-Term Outcome 颈动脉内膜切除术后的并发症发生率比较膜片血管成形术和初次闭合:长期结果
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4601
Laura Donder, Vicky Maerens, Heidi Maertens, Kjell Fierens, Anneleen Stockman, Stefanie Buyser, Cedric Coucke, Yves Blomme
Objective: In patients with symptomatic or asymptomatic severe internal carotid artery stenosis, carotid endarterectomy (CEA) has been shown to reduce risk for stroke. The optimal surgical technique remains subject of debate. In the latest European Society of Vascular Surgery (ESVS) guidelines on the management of atherosclerotic carotid disease, routine patching is preferred to routine primary closure. However, there are no RCT’s evaluating selective patching strategies. This follow-up study aimed to assess long term complication rate and restenosis after carotid endarterectomy with selective patching. Methods: Two hundred thirteen consecutive carotid endarterectomies over a 3-year period from January 5th 2011 to December 19th 2013 were prospectively analyzed in a follow-up study over 5 years (mean 4.6, range 3.17-6.17). Patient population consisted of 141 procedures on males and 72 on females with mean age 73 years at the time of surgery (standard deviation (SD) 8.57, range 53-95). There was a follow-up of 89%. Postoperative risk factors were assessed such as hypertension, diabetes mellitus, coronary artery disease and smoking. Postoperative symptoms of cranial nerve injury, transient ischemic events, cerebrovascular events and mortality were evaluated. Duplex ultrasound was performed by a radiologist blinded to the operative technique to evaluate patency of the carotid artery after carotid endarterectomy. Results: Primary closure was used in 110 operations, and patch angioplasty in 103 procedures (Dacron patch). Primary closure was performed when the carotid artery had a diameter above 5 mm, when there was a high carotid bifurcation or when the contralateral carotid artery was occluded. There were no significant differences among groups' baseline characteristics at the time of surgery. Primary closure was performed significantly more in male patients (P= .02). Overall complication rate was 3.76% postoperatively (1.8% after primary closure, 5.8% after patch angioplasty) and after 5 years 5.29% (2.0% after primary closure, 9.1% after patch angioplasty). There are no significant differences in results between the two groups (P= .09 and P= .05). In four cases patients experienced symptoms of cranial nerve damage postoperatively, two in each group. In one of the two cases in each group, the patient fully recovered and the other had persistent complaints (P-value= 1). None of the patients experienced amaurosis fugax during the 5-year follow up period. In five cases a patient had an ipsilateral cerebrovascular thrombosis in the group after patch angioplasty compared to zero in the primary closure group (P-value= .02). In the group of primary closure there was a mortality of 26 patients (23.6%) compared to 26 (25.2%) patients after patch angioplasty (P-value = .70). One was caused by cerebral hyperperfusion syndrome within one month postoperative after patch angioplasty and none were caused by an ipsilateral ischemic stroke. Objective duplex ultrasoun
目的:对于有症状或无症状的严重颈内动脉狭窄患者,颈动脉内膜切除术(CEA)已被证明可以降低卒中的风险。最佳的手术技术仍然是争论的主题。在最新的欧洲血管外科学会(ESVS)关于动脉粥样硬化性颈动脉疾病管理的指南中,常规修补优于常规初级闭合。然而,目前尚无随机对照试验评估选择性修补策略。这项随访研究旨在评估选择性补片颈动脉内膜切除术后的长期并发症发生率和再狭窄。方法:对2011年1月5日至2013年12月19日期间连续进行颈动脉内膜切除术的213例患者进行为期5年的前瞻性随访研究(平均4.6例,范围3.17-6.17例)。患者群体包括141例男性手术和72例女性手术,手术时平均年龄73岁(标准差(SD) 8.57,范围53-95)。随访率为89%。评估术后危险因素,如高血压、糖尿病、冠状动脉疾病和吸烟。观察术后脑神经损伤症状、短暂性脑缺血事件、脑血管事件及死亡率。双工超声由一名不了解手术技术的放射科医生进行,以评估颈动脉内膜切除术后颈动脉的通畅程度。结果:首次闭合110例,膜片血管成形术103例(涤纶补片)。当颈动脉直径大于5mm、颈动脉高分叉或对侧颈动脉闭塞时,进行初级闭合。两组患者手术时的基线特征无显著差异。男性患者的初次闭合率明显高于男性(P= .02)。术后总并发症发生率为3.76%(初次闭合后1.8%,补片成形术后5.8%),5年后为5.29%(初次闭合后2.0%,补片成形术后9.1%)。两组结果比较差异无统计学意义(P= 0.09, P= 0.05)。4例患者术后出现颅神经损伤症状,每组2例。两组各有1例患者完全康复,另1例患者有持续性主诉(p值= 1)。5年随访期间,无一例患者出现黑朦。在5例患者中,补片血管成形术组有同侧脑血管血栓形成,而初次闭合组为零(p值= 0.02)。初次闭合组有26例(23.6%)患者死亡率,而贴片血管成形术组有26例(25.2%)患者死亡率(p值= 0.70)。1例为补片血管成形术后1个月内脑高灌注综合征所致,无一例为同侧缺血性脑卒中所致。目的双超声显示两组再狭窄比较无显著性差异(p值= 0.43)。在12例患者中,再狭窄的发生率在50-70%之间(6例初步闭合和6例血管贴片成形术),没有一例患者出现超过70%的高度再狭窄。患者特征对长期结果没有显著影响。术后使用降压药物与长期卒中(p值= 0.006)、再狭窄(p值= 0.01)和死亡率(p值= 0.003)存在相关性。结论:经过长期随访,我们发现在选定的病例中,初次闭合和补片血管成形术在并发症发生率和再狭窄方面是相同的。应强调最好的药物治疗,特别是使用抗高血压药物。
{"title":"Complication Rate After Carotid Endarterectomy Comparing Patch Angioplasty and Primary Closure: Long-Term Outcome","authors":"Laura Donder, Vicky Maerens, Heidi Maertens, Kjell Fierens, Anneleen Stockman, Stefanie Buyser, Cedric Coucke, Yves Blomme","doi":"10.18103/mra.v11i10.4601","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4601","url":null,"abstract":"Objective: In patients with symptomatic or asymptomatic severe internal carotid artery stenosis, carotid endarterectomy (CEA) has been shown to reduce risk for stroke. The optimal surgical technique remains subject of debate. In the latest European Society of Vascular Surgery (ESVS) guidelines on the management of atherosclerotic carotid disease, routine patching is preferred to routine primary closure. However, there are no RCT’s evaluating selective patching strategies. This follow-up study aimed to assess long term complication rate and restenosis after carotid endarterectomy with selective patching. Methods: Two hundred thirteen consecutive carotid endarterectomies over a 3-year period from January 5th 2011 to December 19th 2013 were prospectively analyzed in a follow-up study over 5 years (mean 4.6, range 3.17-6.17). Patient population consisted of 141 procedures on males and 72 on females with mean age 73 years at the time of surgery (standard deviation (SD) 8.57, range 53-95). There was a follow-up of 89%. Postoperative risk factors were assessed such as hypertension, diabetes mellitus, coronary artery disease and smoking. Postoperative symptoms of cranial nerve injury, transient ischemic events, cerebrovascular events and mortality were evaluated. Duplex ultrasound was performed by a radiologist blinded to the operative technique to evaluate patency of the carotid artery after carotid endarterectomy. Results: Primary closure was used in 110 operations, and patch angioplasty in 103 procedures (Dacron patch). Primary closure was performed when the carotid artery had a diameter above 5 mm, when there was a high carotid bifurcation or when the contralateral carotid artery was occluded. There were no significant differences among groups' baseline characteristics at the time of surgery. Primary closure was performed significantly more in male patients (P= .02). Overall complication rate was 3.76% postoperatively (1.8% after primary closure, 5.8% after patch angioplasty) and after 5 years 5.29% (2.0% after primary closure, 9.1% after patch angioplasty). There are no significant differences in results between the two groups (P= .09 and P= .05). In four cases patients experienced symptoms of cranial nerve damage postoperatively, two in each group. In one of the two cases in each group, the patient fully recovered and the other had persistent complaints (P-value= 1). None of the patients experienced amaurosis fugax during the 5-year follow up period. In five cases a patient had an ipsilateral cerebrovascular thrombosis in the group after patch angioplasty compared to zero in the primary closure group (P-value= .02). In the group of primary closure there was a mortality of 26 patients (23.6%) compared to 26 (25.2%) patients after patch angioplasty (P-value = .70). One was caused by cerebral hyperperfusion syndrome within one month postoperative after patch angioplasty and none were caused by an ipsilateral ischemic stroke. Objective duplex ultrasoun","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135360569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Emerging Storm? Increased Health Inequities in the Context of Racialized Patriarchal Capitalism, Deaths of Despair and Covid-19 一场即将来临的风暴?在种族化的父权制资本主义、绝望死亡和Covid-19背景下,卫生不平等现象加剧
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4414
Carles Muntaner, Virginia Gunn, Seth Prins
his article discusses the gradual increase in Deaths of Despair in the United States, followed by a reversal in the increased life expectancy trend for a subset of the population. This phenomenon is examined in the context of pronounced social and health inequities linked to globalization and capitalism as well as the overall negative implications of the COVID-19 pandemic and subsequent socio-economic crisis, all having the potential to further worsen health and social inequities in the US but also globally. The development of effective and actionable solutions requires an in-depth understanding of the root causes linked to an overall decrease in population-level life expectancy. While focusing on the phenomenon of Death of Despair brings attention to the role of class in the creation of health inequities and increased mortality rates, this approach should be part of a larger examination of contributing factors. Scrutinizing the impact of other social location factors such as race, gender, age, sexual orientation and identity, migration, and citizenship status, along with their interaction is equally important. Research approaches that allow the stratification of analyses by population groups are needed to facilitate a better understanding of the observed decreases in population-level life expectancy. Such approaches require long-term and ongoing investments in research and the intentional collection of indicators that could reveal the breadth and depth of health and social inequities and the pathways through which they lead to increased mortality rates for various population groups. The sustained financial investment and efforts required to examine the causes of decreases in population-level life expectancy and to inform the implementation of protective policies that could reverse this trend have the potential to bring long-term societal dividends. An indirect outcome of the reduction of social and health inequities and the adoption of protective policies could be that individuals and populations regain their trust in social institutions and, as a result, enhance their active political participation through increased voter turnout and decreased political radicalization.
他的文章讨论了美国绝望死亡人数的逐渐增加,随后是一部分人口预期寿命增长趋势的逆转。这一现象是在与全球化和资本主义相关的明显的社会和健康不平等,以及COVID-19大流行和随后的社会经济危机的总体负面影响的背景下进行的,所有这些都有可能进一步加剧美国乃至全球的健康和社会不平等。制定有效和可行的解决办法需要深入了解与人口预期寿命总体下降有关的根本原因。虽然关注绝望之死现象使人们注意到阶级在造成保健不平等和死亡率增加方面的作用,但这一办法应成为对促成因素进行更广泛审查的一部分。仔细研究其他社会位置因素的影响,如种族、性别、年龄、性取向和身份、移民和公民身份,以及它们之间的相互作用也同样重要。需要采用允许按人口群体分层分析的研究方法,以便更好地了解所观察到的人口预期寿命的减少。这种办法需要对研究进行长期和持续的投资,并有意收集能够揭示健康和社会不平等的广度和深度以及这些不平等导致各种人口群体死亡率上升的途径的指标。为审查人口预期寿命下降的原因和为执行可以扭转这一趋势的保护政策提供信息所需的持续财政投资和努力有可能带来长期的社会红利。减少社会和保健不平等以及采取保护性政策的一个间接结果可能是,个人和人口重新获得对社会机构的信任,从而通过增加选民投票率和减少政治激进化来加强他们的积极政治参与。
{"title":"An Emerging Storm? Increased Health Inequities in the Context of Racialized Patriarchal Capitalism, Deaths of Despair and Covid-19","authors":"Carles Muntaner, Virginia Gunn, Seth Prins","doi":"10.18103/mra.v11i10.4414","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4414","url":null,"abstract":"his article discusses the gradual increase in Deaths of Despair in the United States, followed by a reversal in the increased life expectancy trend for a subset of the population. This phenomenon is examined in the context of pronounced social and health inequities linked to globalization and capitalism as well as the overall negative implications of the COVID-19 pandemic and subsequent socio-economic crisis, all having the potential to further worsen health and social inequities in the US but also globally. The development of effective and actionable solutions requires an in-depth understanding of the root causes linked to an overall decrease in population-level life expectancy. While focusing on the phenomenon of Death of Despair brings attention to the role of class in the creation of health inequities and increased mortality rates, this approach should be part of a larger examination of contributing factors. Scrutinizing the impact of other social location factors such as race, gender, age, sexual orientation and identity, migration, and citizenship status, along with their interaction is equally important. Research approaches that allow the stratification of analyses by population groups are needed to facilitate a better understanding of the observed decreases in population-level life expectancy. Such approaches require long-term and ongoing investments in research and the intentional collection of indicators that could reveal the breadth and depth of health and social inequities and the pathways through which they lead to increased mortality rates for various population groups. The sustained financial investment and efforts required to examine the causes of decreases in population-level life expectancy and to inform the implementation of protective policies that could reverse this trend have the potential to bring long-term societal dividends. An indirect outcome of the reduction of social and health inequities and the adoption of protective policies could be that individuals and populations regain their trust in social institutions and, as a result, enhance their active political participation through increased voter turnout and decreased political radicalization.","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135446644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report Liraglutid and insuline resistance 利拉鲁tid和胰岛素抵抗1例
Pub Date : 2023-01-01 DOI: 10.18103/mra.v11i10.4614
Stefan Farsky
Weight reduction in patients with cardiovascular (CV) diseases and concurrent overweight or obesity brings a fundamental improvement in health and prognosis of such diseases, a proven reduction in mortality and morbidity, and is associated with a reduction in pharmacotherapy and the number of hospitalizations, therefore, it is also economically effective. With the current growing trend in population, obesity also becomes a population risk factor that is more significant than smoking, and a leading cause of preventable diseases. From this point of view, the availability of a new effective anti-obesity medication is very welcome, in particular, liraglutide elegantly interferes with the physiological mechanisms regulating food intake. In addition, it reduces the risk of developing diabetes and has anti- atherogenic effects. At the obese diabetic 2 type patients on insulin treatment often resistance develops and in spite of high insuline dosage inadequate control of glucose and HbA1c levels are obvious. We present the extreme case on this topic down: May 2013: first examination dated in our database of cardiology care dept. for out patients, 65 years old man, weight 144 kg, height 178 cm, waist circumferrence 143cm. His history: arterial hypertension since 1993, diabetes 2 type since 2008 on peroral treatment, paroxysmal atrial fibrilation since March 2013, diameter of the left atrium 50mm on ECHO, invasive coronarography negat. Therapy: telmisartan, metoprolol, nitrendipin, warfarin, propafenon, digoxin, spironolacton, statin. November 2013: effect of therapeutic lifestyle changes: regular sinus rhythm, weight 133kg, waist circumferrence 134cm, spironolacton substituted by eplerenon (asymetric gynecomastia), digoxin ex May 2014: weight 126kg, September 2014: atrial fibrilation, propafenon substituted by flekainid, then atrial flutter, switch from flekainid to amiodaron and digoxin, warfarin substituted by apixaban February 2015: sinus rhythm , weight 129kg December 2015: weight 140kg, BP 170/90 mmHg, atrial flutter with a-v blockage 4:1, ankle oedema on both sides, Hb 115g/l, urinary acid 499umol/l, creatinin 119 umol/l, added allopurinol, urapidil, furosemid May 2017: intensification of the diabetes treatment, added insulin application, dosage escalation during the next years, on ECHO: left atriium diameter 52mm, left ventricle diameter 62mm, systolic function of the left ventricle preserved, moderate mitral and tricuspidal regurgitation December 2017: sinus bradycardia 46/min, amiodaron and digoxin ex, sick sinus syndrom brady-tachycardia form, hepatomegaly July 2018: bariatric procedure contraindicated by surgeon because of age and health status December 2018: creatinin 169umol/l, urinary acid 652umol/l October 2019: weight 158 kg, hospitalisation for heart failúre, confirmed by increased NT- BNP level, therapeutic changes from sartan to ARNI, from warfarin to apixaban, increased furosemid dosage. February 2021: weight 159kg, O2 peripheral satura
心血管(CV)疾病合并超重或肥胖患者的体重减轻从根本上改善了这些疾病的健康状况和预后,证实了死亡率和发病率的降低,并与药物治疗和住院次数的减少有关,因此,它在经济上也是有效的。随着目前人口的增长趋势,肥胖也成为比吸烟更重要的人口危险因素,是导致可预防疾病的主要原因。从这个角度来看,一种新的有效的抗肥胖药物的可用性是非常受欢迎的,特别是利拉鲁肽巧妙地干扰了调节食物摄入的生理机制。此外,它还能降低患糖尿病的风险,并具有抗动脉粥样硬化的作用。肥胖的2型糖尿病患者在接受胰岛素治疗时经常出现抵抗,尽管胰岛素剂量很高,但血糖和糖化血红蛋白水平的控制明显不足。我们在2013年5月提出了这个主题的极端案例:在我们的心脏病护理部门数据库中首次检查门诊患者,65岁男性,体重144公斤,身高178厘米,腰围143厘米。病史:1993年开始动脉高血压,2008年开始口服治疗2型糖尿病,2013年3月开始阵发性心房颤动,超声左心房直径50mm,有创冠状造影阴性。治疗:替米沙坦,美托洛尔,尼群地平,华法林,普罗帕南,地高辛,螺内酯,他汀类药物。2013年11月:治疗性生活方式改变效果:窦性心律正常,体重133kg,腰围134cm,安替乐酮(不对称型男性乳房发育),地高辛停用,2014年5月:体重126kg, 2014年9月:房颤,用氟来卡因替代普帕酮,然后心房扑动,由氟来卡因改用胺碘酮和地高辛,华法林替代阿哌沙班2015年2月:窦性心律,体重129kg 2015年12月:体重140kg,血压170/ 90mmhg,心房扑动合并a-v阻塞4:1,双侧踝关节水肿,Hb 115g/l,尿酸499umol/l,创造素119 umol/l,添加别嘌呤醇、乌拉地尔、速尿,2017年5月:糖尿病治疗强化,添加胰岛素应用,未来几年剂量增加,ECHO:左心房直径52mm,左心室直径62mm,左心室收缩功能保留,二尖瓣和三尖瓣中度反流2017年12月:2018年7月:由于年龄和健康状况,外科医生禁止进行减肥手术2018年12月:创造素169umol/l,尿酸652umol/l 2019年10月:体重158 kg,因心脏住院failúre,证实NT- BNP水平升高,治疗从沙坦到ARNI,从华法林到阿哌沙班,尿速减慢剂量增加。2021年2月:体重159kg,外周血氧饱和度93%,开始部分禁食(8:16)2021年5月:明显呼吸困难,NYHA III, ECHO:左心房直径56mm,左心室直径70mm,左心室EF 0.50, E/A 0.70, 2022年3月7日:由于解剖性静脉异常,尝试植入永久性心脏刺激装置失败。脑MRI:右侧脑额区缺血后缺损创素220 μ mol/l,钾5,4 mmol/l,血红蛋白121 g/l,糖尿病肾病。体重160公斤。添加铁补充剂。尽管胰岛素剂量很高(Humalog 3x20单位和basal 2x50单位),每天160单位,血糖水平约为20mmol/l, 2022年7月:体重161 kg,开始利拉鲁tid每日应用0.6 mg s.c,剂量每周增加到1,2,2,4,3,0 mg。2022年10月:饥饿感明显减少,吃得更少了,没有了想吃主食的时间安排。在利拉鲁tid应用的前3个月,体重减少到151公斤(cca每天减100克),胰岛素剂量减少到每天60单位(Humalog ex,基础胰岛素减少到60单位),同时血糖水平显著降低到8 mmol/l左右。血凝素为166 umol/l,尿酸为323 umol/l。2023年1月:体重157kg,脂肪含量50%,水分含量40%。ECHO:左心室内径60mm, EF 0.5,左心房内径54mm,未见三尖瓣反流,E/A 0.7。创造素128 mmol/l,钾4.5 mmol/l。
{"title":"Case report Liraglutid and insuline resistance","authors":"Stefan Farsky","doi":"10.18103/mra.v11i10.4614","DOIUrl":"https://doi.org/10.18103/mra.v11i10.4614","url":null,"abstract":"Weight reduction in patients with cardiovascular (CV) diseases and concurrent overweight or obesity brings a fundamental improvement in health and prognosis of such diseases, a proven reduction in mortality and morbidity, and is associated with a reduction in pharmacotherapy and the number of hospitalizations, therefore, it is also economically effective. With the current growing trend in population, obesity also becomes a population risk factor that is more significant than smoking, and a leading cause of preventable diseases. From this point of view, the availability of a new effective anti-obesity medication is very welcome, in particular, liraglutide elegantly interferes with the physiological mechanisms regulating food intake. In addition, it reduces the risk of developing diabetes and has anti- atherogenic effects. At the obese diabetic 2 type patients on insulin treatment often resistance develops and in spite of high insuline dosage inadequate control of glucose and HbA1c levels are obvious. We present the extreme case on this topic down: May 2013: first examination dated in our database of cardiology care dept. for out patients, 65 years old man, weight 144 kg, height 178 cm, waist circumferrence 143cm. His history: arterial hypertension since 1993, diabetes 2 type since 2008 on peroral treatment, paroxysmal atrial fibrilation since March 2013, diameter of the left atrium 50mm on ECHO, invasive coronarography negat. Therapy: telmisartan, metoprolol, nitrendipin, warfarin, propafenon, digoxin, spironolacton, statin. November 2013: effect of therapeutic lifestyle changes: regular sinus rhythm, weight 133kg, waist circumferrence 134cm, spironolacton substituted by eplerenon (asymetric gynecomastia), digoxin ex May 2014: weight 126kg, September 2014: atrial fibrilation, propafenon substituted by flekainid, then atrial flutter, switch from flekainid to amiodaron and digoxin, warfarin substituted by apixaban February 2015: sinus rhythm , weight 129kg December 2015: weight 140kg, BP 170/90 mmHg, atrial flutter with a-v blockage 4:1, ankle oedema on both sides, Hb 115g/l, urinary acid 499umol/l, creatinin 119 umol/l, added allopurinol, urapidil, furosemid May 2017: intensification of the diabetes treatment, added insulin application, dosage escalation during the next years, on ECHO: left atriium diameter 52mm, left ventricle diameter 62mm, systolic function of the left ventricle preserved, moderate mitral and tricuspidal regurgitation December 2017: sinus bradycardia 46/min, amiodaron and digoxin ex, sick sinus syndrom brady-tachycardia form, hepatomegaly July 2018: bariatric procedure contraindicated by surgeon because of age and health status December 2018: creatinin 169umol/l, urinary acid 652umol/l October 2019: weight 158 kg, hospitalisation for heart failúre, confirmed by increased NT- BNP level, therapeutic changes from sartan to ARNI, from warfarin to apixaban, increased furosemid dosage. February 2021: weight 159kg, O2 peripheral satura","PeriodicalId":18641,"journal":{"name":"Medical Research Archives","volume":"426 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135446651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Research Archives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1